Evogene Stock Performance

Evogene Relative Risk vs. Return Landscape

If you would invest  126.00  in Evogene on November 2, 2025 and sell it today you would lose (25.00) from holding Evogene or give up 19.84% of portfolio value over 90 days. Evogene is currently does not generate positive expected returns and assumes 3.6704% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than Evogene, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Evogene is expected to under-perform the market. In addition to that, the company is 4.91 times more volatile than its market benchmark. It trades about -0.08 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Evogene Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 1.18 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Evogene will likely underperform. Additionally Evogene has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Evogene

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evogene. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.05 1.01 4.68 Details

Intrinsic Valuation Low Real High 0.07 1.36 5.03 Details

Naive Forecast Low Next High 0.02 1.00 4.67 Details

2 Analysts Consensus Low Target High 2.28 2.50 2.78 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Evogene. Your research has to be compared to or analyzed against Evogene's peers to derive any actionable benefits. When done correctly, Evogene's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Evogene.

Evogene Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Evogene is not an exception. The market had few large corrections towards the Evogene's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Evogene, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Evogene within the framework of very fundamental risk indicators.

Evogene Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Evogene for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Evogene can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Evogene Price Density Drivers

Evogene Fundamentals Growth

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evogene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Will Biotechnology sector continue expanding? Could Evogene diversify its offerings? Factors like these will boost the valuation of Evogene. Projected growth potential of Evogene fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Evogene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Investors evaluate Evogene using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Evogene's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Evogene's market price to deviate significantly from intrinsic value.

It's important to distinguish between Evogene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evogene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Evogene's market price signifies the transaction level at which participants voluntarily complete trades.